RNS Announcements re: PUBLICATION OF SUPPLEMENT
The following supplement has been approved by the Financial Conduct Authority and is available for viewing:
Supplement dated 20 December 2024 (the Supplement) to the Bank of Queensland Limited (the Issuer) Information Memorandum dated 24 April 2024 in respect of the U.S.$4,000,000,000 BOQ Euro Medium Term Note Programme (together, the Information Memorandum).
To view the full document, please paste the following URL into the address bar of your browser.
http://www.rns-pdf.londonstockexchange.com/rns/0904R_1-2024-12-22.pdf
In addition, the Issuer has published its 2024 Annual Report on its website at https://www.boq.com.au/content/dam/boq/microsites/annual-reports/2024/2024-Annual-Report.pdf (the 2024 Annual Report).
A copy of the Supplement and the 2024 Annual Report has also been submitted to the National Storage Mechanism and will shortly be available for inspection at https://data.fca.org.uk/#/nsm/nationalstoragemechanism.
For further information, please contact:
Bank of Queensland Limited
Tim Blumke
100 Skyring Terrace Newstead, QLD, Australia 4006
Telephone: +61 (0)450 759 320
Email: tim.blumke@boq.com.au
DISCLAIMER - INTENDED ADDRESSEES
Please note that the information contained in the Information Memorandum may be addressed to and/or targeted at persons who are residents of particular countries (specified in the Information Memorandum) only and is not intended for use and should not be relied upon by any person outside these countries and/or to whom the offer contained in the Information Memorandum is not addressed. Prior to relying on the information contained in the Information Memorandum you must ascertain from the Information Memorandum whether or not you are part of the intended addressees of the information contained therein.
Your right to access this service is conditional upon complying with the above requirement.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.